Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Adami, Hans-Olov
overview With a long background as a practicing surgeon with a focus on oncology, I have always conducted clinical and epidemiologic research in parallel. My clinical research includes randomized trials, prognostic studies, and studies of clinical issues using an observational study design. Over the years, however, my focus has been on cancer epidemiology, and I have worked on a large number of cancer sites and types. Currently, I am working predominantly on prostate cancer, (with research ranging from genetic association studies to randomized trials of radical surgical treatment, and prediction of outcome using molecular and genetic markers), malignant lymphomas, cervical cancer (with a focus on viral load as a possible determinant of progression from precursors to invasive cancer), and breast cancer. I am also involved in planning a large prospective cohort study in Sweden, and integrating this with other similar initiatives around the globe. Other Affiliations Professor Emeritus, Karolinska Institutet, Stockholm, Sweden Associate Director of Populations Sciences, Dana Farber/Harvard Cancer Center Research My research is devoted chiefly, but not entirely to cancer epidemiology. Within that area, I have been interested in a large number of cancer sites and types and carried out both prospective and case-control studies often on a large-scale within Sweden. Hence, we have conducted nation-wide case-control studies in Sweden on cancers of the breast, cervix, endometrium, ovary, anus, esophagus, non-Hodgkin’s lymphomas, Hodgkin’s lymphomas, kidney cancer and prostate cancer. Much of my research over the last decade has been carried out in close collaboration with professor Trichopoulos at the Harvard School of Public Health and also with other researchers, post docs and graduate students at the SPH. Presently, this work is expanding also into realm of prostate cancer in collaboration with the Dana Farber Cancer Institute. Beside etiologic research into the causes of cancer, I have also a long-standing interest in clinical research including randomized trials, cancer screening and analysis of prognostic factors. A large part of the research carried out at Harvard and at the Karolinska Institutet in Stockholm takes advantage of unique prerequisites for epidemiologic research in Sweden, including nation-wide cancer registration, a public health care system that allows retrieval of information, hospital records, tissue specimens etc., and an expanding number of national health data bases that can be cross-linked using the individually unique national registration number assigned to all residents in Sweden. This registration number also enables complete follow-up long-term of virtually all individuals included in epidemiologic and clinical studies. In recent years, collaboration and exchange of Junior Faculty, post docs and graduate students has become an important ingredient in the research carried out collaboratively between Karolinska Institutet and the Harvard School of Public Health. Given the enormous prerequisites for epidemiologic research in Sweden, this is an untapped resource and we have a keen interest in both recruiting post docs from the School of Public Health and in offering graduate students at Harvard opportunities to use Swedish data sources and on-going studies for their thesis work. More information about these opportunities can be obtained for example from Dr. Lorelei Mucci and from Dr. Ellen Chang.
One or more keywords matched the following items that are connected to Adami, Hans-Olov
Item TypeName
Academic Article Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
Academic Article Optimization of cervical cancer screening.
Academic Article [Prevention and early diagnosis of cancer. What do we know? What do we think? Reports from the Lakardagarna in Orebro].
Academic Article [Politics and science in colorectal cancer screening].
Academic Article Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden.
Academic Article Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Academic Article [Politics and science in colorectal cancer screening].
Academic Article Screening for prostate cancer remains controversial.
Academic Article The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.
Academic Article Ethics of a prostate cancer screening trial.
Concept Early Detection of Cancer
Academic Article Screening, case finding or primary cancer prevention in the developing world?
Academic Article Current status of screening for colorectal cancer.
Academic Article Too much mammography.
Academic Article Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway.
Academic Article Long-term risk of colorectal cancer in individuals with serrated polyps.
Academic Article Do's and don'ts in evaluation of endoscopic screening for gastrointestinal cancers.
Academic Article The continuing uncertainty about cancer risk in inflammatory bowel disease.
Academic Article Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention.
Academic Article Enigmas, priorities and opportunities in cancer epidemiology.
Academic Article Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.
Academic Article America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.
Academic Article Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
Academic Article Time to abandon early detection cancer screening.
Academic Article Author Reply to: The name of the game: Is preventive screening "cancer screening?"
Academic Article Breast Cancer Screening and Diagnosis.
Academic Article Ongoing Trials Will Not Determine the Comparative Effectiveness of Colorectal Cancer Screening Tests.
Academic Article Assessment of cancer screening effectiveness in the era of screening programs.
Search Criteria
  • Early Detection of Cancer
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.